Oxidative stress in hypoxic-ischemic encephalopathy: Molecular mechanisms and therapeutic strategies

International Journal of Molecular Sciences

Volumn 17, Issue 12, 2016, Pages

  Zhao, Mingyi ^a   Zhu, Ping ^b   Fujino, Masayuki ^c,d   Zhuang, Jian ^b   Guo, Huiming ^b   Sheikh, Idrisahmed ^a   Zhao, Lingling ^a   Li, Xiao Kang ^a,c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Cell damage; Hypoxic ischemic encephalopathy; Oxidative stress; Therapeutic strategy; Therapeutic strategy oxidative stress

Indexed keywords

ALLOPURINOL; BIM PROTEIN; CASPASE 3; ENDOTHELIN 1; ERYTHROPOIETIN; FLUNARIZINE; HYDROGEN PEROXIDE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; MAGNESIUM SULFATE; MELATONIN; N ACETYLSEROTONIN; NALOXONE; NITRIC OXIDE; NORPHENAZONE; OSTEOPONTIN; PROTEIN BAD; PROTEIN BAK; PROTEIN BAX; PROTEIN BID; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; ANTIOXIDANT; BIOLOGICAL MARKER;

APOPTOSIS; AUTOPHAGY; CHINESE MEDICINE; COMPUTER ASSISTED TOMOGRAPHY; CYTOKINE PRODUCTION; DOPPLER ULTRASONOGRAPHY; ELECTROENCEPHALOGRAPHY; ENZYME RELEASE; HUMAN; HYPOTHERMIA; HYPOXIC ISCHEMIC ENCEPHALOPATHY; MITOCHONDRIAL ENERGY TRANSFER; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVIEW; ANIMAL; HYPOXIA-ISCHEMIA, BRAIN; METABOLISM; PATHOLOGY;

ANIMALS; ANTIOXIDANTS; BIOMARKERS; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 85006138298     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17122078     Document Type: Review

References (106)

1. Allen, C.L.; Bayraktutan, U. Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int. J. Stroke Off. J. Int. Stroke Soc. 2009, 4, 461–470.
2. Ikonomidou, C.; Kaindl, A.M. Neuronal death and oxidative stress in the developing brain. Antioxid. Redox Signal. 2011, 14, 1535–1550.
3. Doyle, K.P.; Simon, R.P.; Stenzel-Poore, M.P. Mechanisms of ischemic brain damage. Neuropharmacology 2008, 55, 310–318.
4. Solovieva, E.Y.; Chipova, D.T. From the conception of “oxidizing stress” to the conception of “cell signaling modulation”. Zh. Nevrol. Psikhiatr. Im. S.S. 2015, 115, 105–111.
5. Hole, P.S.; Darley, R.L.; Tonks, A. Do reactive oxygen species play a role in myeloid leukemias? Blood 2011, 117, 5816–5826.
6. Kayama, Y.; Raaz, U.; Jagger, A.; Adam, M.; Schellinger, I.N.; Sakamoto, M.; Suzuki, H.; Toyama, K.; Spin, J.M.; Tsao, P.S. Diabetic cardiovascular disease induced by oxidative stress. Int. J. Mol. Sci. 2015, 16, 25234–25263.
7. Angeloni, C.; Prata, C.; Dalla Sega, F.V.; Piperno, R.; Hrelia, S. Traumatic brain injury and NADPH oxidase: A deep relationship. Oxid. Med. Cell. Longev. 2015, 2015, 370312.
8. Lu, Q.; Wainwright, M.S.; Harris, V.A.; Aggarwal, S.; Hou, Y.; Rau, T.; Poulsen, D.J.; Black, S.M. Increased NADPH oxidase-derived superoxide is involved in the neuronal cell death induced by hypoxia-ischemia in neonatal hippocampal slice cultures. Free Radic. Biol. Med. 2012, 53, 1139–1151.
9. Wei, I.H.; Huang, C.C.; Tseng, C.Y.; Chang, H.M.; Tu, H.C.; Tsai, M.H.; Wen, C.Y.; Shieh, J.Y. Mild hypoxic preconditioning attenuates injury-induced NADPH-d/nNOS expression in brainstem motor neurons of adult rats. J. Chem. Neuroanat. 2008, 35, 123–132.
10. Wang, Z.; Feng, C.; Zhao, H.; Ren, X.; Peng, S.; Zuo, Z. Autoregulation of inducible nitric oxide synthase expression by RNA interference provides neuroprotection in neonatal rats. Theranostics 2015, 5, 504–514.
11. Liu, H.; Li, J.; Zhao, F.; Wang, H.; Qu, Y.; Mu, D. Nitric oxide synthase in hypoxic or ischemic brain injury. Rev. Neurosci. 2015, 26, 105–117.
12. Liu, Y.; Li, W.; Hu, L.; Liu, Y.; Li, B.; Sun, C.; Zhang, C.; Zou, L. Downregulation of nitric oxide by electroacupuncture against hypoxicischemic brain damage in rats via nuclear factor κB/neuronal nitric oxide synthase. Mol. Med. Rep. 2015, 11, 837–842.
13. Yu, L.; Yi, J.; Ye, G.; Zheng, Y.; Song, Z.; Yang, Y.; Song, Y.; Wang, Z.; Bao, Q. Effects of curcumin on levels of nitric oxide synthase and AQP-4 in a rat model of hypoxia-ischemic brain damage. Brain Res. 2012, 1475, 88–95.
14. Kuzmanic Samija, R.; Primorac, D.; Resic, B.; Pavlov, V.; Capkun, V.; Punda, H.; Lozic, B.; Zemunik, T. Association of NOS3 gene variants and clinical contributors of hypoxic-ischemic encephalopathy. Braz. J. Med. Biol. Res. Rev. Bras. Pesqui. Med. E Biol. Soc. Bras. Biofisica 2014, 47, 869–875.
15. Drobyshevsky, A.; Yu, L.; Yang, Y.; Khalid, S.; Luo, K.; Jiang, R.; Ji, H.; Derrick, M.; Kay, L.; Silverman, R.B. et al. Antenatal insults modify newborn olfactory function by nitric oxide produced from neuronal nitric oxide synthase. Exp. Neurol. 2012, 237, 427–434.
16. Mao, P.; Ardeshiri, A.; Jacks, R.; Yang, S.; Hurn, P.D.; Alkayed, N.J. Mitochondrial mechanism of neuroprotection by CART. Eur. J. Neurosci. 2007, 26, 624–632.
17. Jin, R.; Yang, G.; Li, G. Inflammatory mechanisms in ischemic stroke: Role of inflammatory cells. J. Leukoc. Biol. 2010, 87, 779–789.
18. Doverhag, C.; Keller, M.; Karlsson, A.; Hedtjarn, M.; Nilsson, U.; Kapeller, E.; Sarkozy, G.; Klimaschewski, L.; Humpel, C.; Hagberg, H. et al. Pharmacological and genetic inhibition of NADPH oxidase does not reduce brain damage in different models of perinatal brain injury in newborn mice. Neurobiol. Dis. 2008, 31, 133–144.
19. Tang, X.N.; Cairns, B.; Kim, J.Y.; Yenari, M.A. NADPH oxidase in stroke and cerebrovascular disease. Neurol. Res. 2012, 34, 338–345.
20. Douglas-Escobar, M.; Weiss, M.D. Hypoxic-ischemic encephalopathy: A review for the clinician. JAMA Pediatr. 2015, 169, 397–403.
21. Goergen, S.K.; Ang, H.; Wong, F.; Carse, E.A.; Charlton, M.; Evans, R.; Whiteley, G.; Clark, J.; Shipp, D.; Jolley, D. et al. Early MRI in term infants with perinatal hypoxic-ischaemic brain injury: Interobserver agreement and MRI predictors of outcome at 2 years. Clin. Radiol. 2014, 69, 72–81.
22. Rutherford, M.; Biarge, M.M.; Allsop, J.; Counsell, S.; Cowan, F. MRI of perinatal brain injury. Pediatr. Radiol. 2010, 40, 819–833.
23. Heinz, E.R.; Provenzale, J.M. Imaging findings in neonatal hypoxia: A practical review. AJR. Am. J. Roentgenol. 2009, 192, 41–47.
24. Awal, M.A.; Lai, M.M.; Azemi, G.; Boashash, B.; Colditz, P.B. EEG background features that predict outcome in term neonates with hypoxic ischaemic encephalopathy: A structured review. Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol. 2015, 127, 285–296.
25. Ramaswamy, V.; Horton, J.; Vandermeer, B.; Buscemi, N.; Miller, S.; Yager, J. Systematic review of biomarkers of brain injury in term neonatal encephalopathy. Pediatr. Neurol. 2009, 40, 215–226.
26. Gazzolo, D.; Abella, R.; Marinoni, E.; di Iorio, R.; Li Volti, G.; Galvano, F.; Frigiola, A.; Temporini, F.; Moresco, L.; Colivicchi, M. et al. New markers of neonatal neurology. J. Mater.-Fetal Neonatal Med. Off. J. Eur. Assoc. Perinat. Med. Fed. Asia Ocean. Perinat. Soc. Int. Soc. Perinat. Obstet. 2009, 22, 57–61.
27. Lv, H.; Wang, Q.; Wu, S.; Yang, L.; Ren, P.; Yang, Y.; Gao, J.; Li, L. Neonatal hypoxic ischemic encephalopathy-related biomarkers in serum and cerebrospinal fluid. Clin. Chim. Acta Int. J. Clin. Chem. 2015, 450, 282–297.
28. Kaur, C.; Rathnasamy, G.; Ling, E.A. Roles of activated microglia in hypoxia induced neuroinflammation in the developing brain and the retina. J. Neuroimmune Pharmacol. Off. J. Soc. Neuroimmune Pharmacol. 2013, 8, 66–78.
29. Jellema, R.K.; Lima Passos, V.; Zwanenburg, A.; Ophelders, D.R.; de Munter, S.; Vanderlocht, J.; Germeraad, W.T.; Kuypers, E.; Collins, J.J.; Cleutjens, J.P. et al. Cerebral inflammation and mobilization of the peripheral immune system following global hypoxia-ischemia in preterm sheep. J. Neuroinflamm. 2013, 10, 13.
30. Tuttolomondo, A.; di Raimondo, D.; di Sciacca, R.; Pinto, A.; Licata, G. Inflammatory cytokines in acute ischemic stroke. Curr. Pharm. Des. 2008, 14, 3574–3589.
31. Brait, V.H.; Jackman, K.A.; Walduck, A.K.; Selemidis, S.; Diep, H.; Mast, A.E.; Guida, E.; Broughton, B.R.; Drummond, G.R.; Sobey, C.G. Mechanisms contributing to cerebral infarct size after stroke: Gender, reperfusion, T lymphocytes, and Nox2-derived superoxide. J. Cereb. Blood Flow Metab. Off. J. Int. Soc. Cereb. Blood Flow Metab. 2010, 30, 1306–1317.
32. Wang, J.; Lu, Q. Expression of T subsets and mIL-2R in peripheral blood of newborns with hypoxic ischemic encephalopathy. World J. Pediatr. WJP 2008, 4, 140–144.
33. Becker, K.J. Activation of immune responses to brain antigens after stroke. J. Neurochem. 2012, 123, 148–155.
34. Liu, J.; Feng, Z.C. Increased umbilical cord plasma interleukin-1 β levels was correlated with adverse outcomes of neonatal hypoxic-ischemic encephalopathy. J. Trop. Pediatr. 2010, 56, 178–182.
35. Girard, S.; Sebire, H.; Brochu, M.E.; Briota, S.; Sarret, P.; Sebire, G. Postnatal administration of IL-1Ra exerts neuroprotective effects following perinatal inflammation and/or hypoxic-ischemic injuries. Brain Behav. Immun. 2012, 26, 1331–1339.
36. Green, H.F.; Treacy, E.; Keohane, A.K.; Sullivan, A.M.; O’Keeffe, G.W.; Nolan, Y.M. A role for interleukin-1β in determining the lineage fate of embryonic rat hippocampal neural precursor cells. Mol. Cell. Neurosci. 2012, 49, 311–321.
37. Favrais, G.; van de Looij, Y.; Fleiss, B.; Ramanantsoa, N.; Bonnin, P.; Stoltenburg-Didinger, G.; Lacaud, A.; Saliba, E.; Dammann, O.; Gallego, J. et al. Systemic inflammation disrupts the developmental program of white matter. Ann. Neurol. 2011, 70, 550–565.
38. Mirabelli-Badenier, M.; Braunersreuther, V.; Viviani, G.L.; Dallegri, F.; Quercioli, A.; Veneselli, E.; Mach, F.; Montecucco, F. CC and CXC chemokines are pivotal mediators of cerebral injury in ischaemic stroke. Thromb. Haemost. 2011, 105, 409–420.
39. Ablikim, M.; Achasov, M.N.; Ai, X.C.; Albayrak, O.; Albrecht, M.; Ambrose, D.J.; An, F.F.; An, Q.; Bai, J.Z.; Baldini Ferroli, R. et al. Observation of eta′-->pi+ pi pi+ pi- and eta′-->pi+ pi- pi0 pi0. Phys. Rev. Lett. 2014, 112, 251801.
40. Acin-Perez, R.; Hoyos, B.; Gong, J.L.; Vinogradov, V.; Fischman, D.A.; Leitges, M.; Borhan, B.; Starkov, A.; Manfredi, G.; Hammerling, U. Regulation of intermediary metabolism by the PKCδ signalosome in mitochondria. FASEB J. 2010, 24, 5033–5042.
41. Sanderson, T.H.; Reynolds, C.A.; Kumar, R.; Przyklenk, K.; Huttemann, M. Molecular mechanisms of ischemia-reperfusion injury in brain: Pivotal role of the mitochondrial membrane potential in reactive oxygen species generation. Mol. Neurobiol. 2013, 47, 9–23.
42. Nakka, V.P.; Gusain, A.; Mehta, S.L.; Raghubir, R. Molecular mechanisms of apoptosis in cerebral ischemia: Multiple neuroprotective opportunities. Mol. Neurobiol. 2008, 37, 7–38.
43. Hardwick, J.M.; Chen, Y.B.; Jonas, E.A. Multipolar functions of BCL-2 proteins link energetics to apoptosis. Trends Cell Biol. 2012, 22, 318–328.
44. Orrenius, S.; Gogvadze, V.; Zhivotovsky, B. Mitochondrial oxidative stress: Implications for cell death. Annu. Rev. Pharmacol. Toxicol. 2007, 47, 143–183.
45. Yu, Y.; Tang, D.; Kang, R. Oxidative stress-mediated HMGB1 biology. Front. Physiol. 2015, 6, 93.
46. Kroemer, G.; Galluzzi, L.; Brenner, C. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 2007, 87, 99–163.
47. Bayir, H.; Kagan, V.E. Bench-to-bedside review: Mitochondrial injury, oxidative stress and apoptosis—There is nothing more practical than a good theory. Crit. Care 2008, 12, 206.
48. Wang, P.; Miao, C.Y. Autophagy in the disorders of central nervous system: Vital and/or fatal? CNS Neurosci. Ther. 2012, 18, 955–956.
49. Wei, K.; Wang, P.; Miao, C.Y. A double-edged sword with therapeutic potential: An updated role of autophagy in ischemic cerebral injury. CNS Neurosci. Ther. 2012, 18, 879–886.
50. Singh, R.; Kaushik, S.; Wang, Y.; Xiang, Y.; Novak, I.; Komatsu, M.; Tanaka, K.; Cuervo, A.M.; Czaja, M.J. Autophagy regulates lipid metabolism. Nature 2009, 458, 1131–1135.
51. Gonzalez, C.D.; Lee, M.S.; Marchetti, P.; Pietropaolo, M.; Towns, R.; Vaccaro, M.I.; Watada, H.; Wiley, J.W. The emerging role of autophagy in the pathophysiology of diabetes mellitus. Autophagy 2011, 7, 2–11.
52. Zhou, R.; Yazdi, A.S.; Menu, P.; Tschopp, J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011, 469, 221–225.
53. Hall, J.C.; Crawford, H.C. The conspiracy of autophagy, stress and inflammation in acute pancreatitis. Curr. Opin. Gastroenterol. 2014, 30, 495–499.
54. Scherz-Shouval, R.; Elazar, Z. Regulation of autophagy by ROS: Physiology and pathology. Trends Biochem. Sci. 2011, 36, 30–38.
55. Farooqi, A.A.; Fayyaz, S.; Hou, M.F.; Li, K.T.; Tang, J.Y.; Chang, H.W. Reactive oxygen species and autophagy modulation in non-marine drugs and marine drugs. Mar. Drugs 2014, 12, 5408–5424.
56. Alva, N.; Palomeque, J.; Carbonell, T. Oxidative stress and antioxidant activity in hypothermia and rewarming: Can RONS modulate the beneficial effects of therapeutic hypothermia? Oxid. Med. Cell. Longev. 2013, 2013, 957054.
57. Bayir, H.; Adelson, P.D.; Wisniewski, S.R.; Shore, P.; Lai, Y.; Brown, D.; Janesko-Feldman, K.L.; Kagan, V.E.; Kochanek, P.M. Therapeutic hypothermia preserves antioxidant defenses after severe traumatic brain injury in infants and children. Crit. Care Med. 2009, 37, 689–695.
58. Silveira, R.C.; Procianoy, R.S. Hypothermia therapy for newborns with hypoxic ischemic encephalopathy. J. Pediatr. 2015, 91, S78–S83.
59. Robertson, N.J.; Tan, S.; Groenendaal, F.; van Bel, F.; Juul, S.E.; Bennet, L.; Derrick, M.; Back, S.A.; Valdez, R.C.; Northington, F. et al. Which neuroprotective agents are ready for bench to bedside translation in the newborn infant? J. Pediatr. 2012, 160, 544–552.
60. Park, M.H.; Lee, S.M.; Lee, J.W.; Son, D.J.; Moon, D.C.; Yoon, D.Y.; Hong, J.T. ERK-mediated production of neurotrophic factors by astrocytes promotes neuronal stem cell differentiation by erythropoietin. Biochem. Biophys. Res. Commun. 2006, 339, 1021–1028.
61. Lee, S.T.; Chu, K.; Sinn, D.I.; Jung, K.H.; Kim, E.H.; Kim, S.J.; Kim, J.M.; Ko, S.Y.; Kim, M.; Roh, J.K. Erythropoietin reduces perihematomal inflammation and cell death with eNOS and STAT3 activations in experimental intracerebral hemorrhage. J. Neurochem. 2006, 96, 1728–1739.
62. Shankaran, S. Outcomes of hypoxic-ischemic encephalopathy in neonates treated with hypothermia. Clin. Perinatol. 2014, 41, 149–159.
63. Elmahdy, H.; El-Mashad, A.R.; El-Bahrawy, H.; El-Gohary, T.; El-Barbary, A.; Aly, H. Human recombinant erythropoietin in asphyxia neonatorum: Pilot trial. Pediatrics 2010, 125, e1135–e1142.
64. Traudt, C.M.; McPherson, R.J.; Bauer, L.A.; Richards, T.L.; Burbacher, T.M.; McAdams, R.M.; Juul, S.E. Concurrent erythropoietin and hypothermia treatment improve outcomes in a term nonhuman primate model of perinatal asphyxia. Dev. Neurosci. 2013, 35, 491–503.
65. Fang, A.Y.; Gonzalez, F.F.; Sheldon, R.A.; Ferriero, D.M. Effects of combination therapy using hypothermia and erythropoietin in a rat model of neonatal hypoxia-ischemia. Pediatr. Res. 2013, 73, 12–17.
66. Fan, X.; van Bel, F.; van der Kooij, M.A.; Heijnen, C.J.; Groenendaal, F. Hypothermia and erythropoietin for neuroprotection after neonatal brain damage. Pediatr. Res. 2013, 73, 18–23.
67. Alonso-Alconada, D.; Alvarez, A.; Arteaga, O.; Martinez-Ibarguen, A.; Hilario, E. Neuroprotective effect of melatonin: A novel therapy against perinatal hypoxia-ischemia. Int. J. Mol. Sci. 2013, 14, 9379–9395.
68. Carloni, S.; Perrone, S.; Buonocore, G.; Longini, M.; Proietti, F.; Balduini, W. Melatonin protects from the long-term consequences of a neonatal hypoxic-ischemic brain injury in rats. J. Pineal Res. 2008, 44, 157–164.
69. Robertson, N.J.; Faulkner, S.; Fleiss, B.; Bainbridge, A.; Andorka, C.; Price, D.; Powell, E.; Lecky-Thompson, L.; Thei, L.; Chandrasekaran, M. et al. Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model. Brain J. Neurol. 2013, 136, 90–105.
70. Aly, H.; Elmandy, H.; El-Dib, M.; Rowisha, M.; Awny, M.; El-Gohary, T.; Elbatcht, M.; Hamisa, M.; El-Mashad, A.R. Melatonin use for neuroprotection in perinatal asphyxia: A randomized controlled pilot study. J. Perinatol. 2015, 35, 186–191.
71. Zhou, H.; Wang, J.; Jiang, J.; Stavrovskaya, I.G.; Li, M.; Li, W.; Wu, Q.; Zhang, X.; Luo, C.; Zhou, S. et al. N-acetyl-serotonin offers neuroprotection through inhibiting mitochondrial death pathways and autophagic activation in experimental models of ischemic injury. J. Neurosci. Off. J. Soc. Neurosci. 2014, 34, 2967–2978.
72. Westermaier, T.; Stetter, C.; Vince, G.H.; Pham, M.; Tejon, J.P.; Eriskat, J.; Kunze, E.; Matthies, C.; Ernestus, R.I.; Solymosi, L. et al. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: A randomized, placebo-controlled, clinical study. Crit. Care Med. 2010, 38, 1284–1290.
73. Cetinkaya, M.; Alkan, T.; Ozyener, F.; Kafa, I.M.; Kurt, M.A.; Koksal, N. Possible neuroprotective effects of magnesium sulfate and melatonin as both pre- and post-treatment in a neonatal hypoxic-ischemic rat model. Neonatology 2011, 99, 302–310.
74. Haramati, O.; Mane, R.; Molczadzki, G.; Perez-Polo, J.R.; Chalifa-Caspi, V.; Golan, H.M. Magnesium sulfate treatment alters fetal cerebellar gene expression responses to hypoxia. Int. J. Dev. Neurosci. Off. J. Int. Soc. Dev. Neurosci. 2010, 28, 207–216.
75. 4. Neonatology 2009, 95, 33–40.
76. Doyle, L.W.; Crowther, C.A.; Middleton, P.; Marret, S. Antenatal magnesium sulfate and neurologic outcome in preterm infants: A systematic review. Obstet. Gynecol. 2009, 113, 1327–1333.
77. Conde-Agudelo, A.; Romero, R. Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks′ gestation: A systematic review and metaanalysis. Am. J. Obstet. Gynecol. 2009, 200, 595–609.
78. Cotten, C.M.; Murtha, A.P.; Goldberg, R.N.; Grotegut, C.A.; Smith, P.B.; Goldstein, R.F.; Fisher, K.A.; Gustafson, K.E.; Waters-Pick, B.; Swamy, G.K. et al. Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy. J. Pediatr. 2014, 164, 973–979.
79. Doycheva, D.; Shih, G.; Chen, H.; Applegate, R.; Zhang, J.H.; Tang, J. Granulocyte-colony stimulating factor in combination with stem cell factor confers greater neuroprotection after hypoxic-ischemic brain damage in the neonatal rats than a solitary treatment. Transl. Stroke Res. 2013, 4, 171–178.
80. Cameron, S.H.; Alwakeel, A.J.; Goddard, L.; Hobbs, C.E.; Gowing, E.K.; Barnett, E.R.; Kohe, S.E.; Sizemore, R.J.; Oorschot, D.E. Delayed post-treatment with bone marrow-derived mesenchymal stem cells is neurorestorative of striatal medium-spiny projection neurons and improves motor function after neonatal rat hypoxia-ischemia. Mol. Cell. Neurosci. 2015, 68, 56–72.
81. Gonzales-Portillo, G.S.; Reyes, S.; Aguirre, D.; Pabon, M.M.; Borlongan, C.V. Stem cell therapy for neonatal hypoxic-ischemic encephalopathy. Front. Neurol. 2014, 5, 147.
82. Park, W.S.; Sung, S.I.; Ahn, S.Y.; Yoo, H.S.; Sung, D.K.; Im, G.H.; Choi, S.J.; Chang, Y.S. Hypothermia augments neuroprotective activity of mesenchymal stem cells for neonatal hypoxic-ischemic encephalopathy. PLoS ONE 2015, 10, e0120893.
83. Noor, J.I.; Ueda, Y.; Ikeda, T.; Ikenoue, T. Edaravone inhibits lipid peroxidation in neonatal hypoxic-ischemic rats: An in vivo microdialysis study. Neurosci. Lett. 2007, 414, 5–9.
84. Takizawa, Y.; Miyazawa, T.; Nonoyama, S.; Goto, Y.; Itoh, M. Edaravone inhibits DNA peroxidation and neuronal cell death in neonatal hypoxic-ischemic encephalopathy model rat. Pediatr. Res. 2009, 65, 636–641.
85. Yoshida, H.; Mimura, J.; Imaizumi, T.; Matsumiya, T.; Ishikawa, A.; Metoki, N.; Tanji, K.; Ota, K.; Hayakari, R.; Kosaka, K. et al. Edaravone and carnosic acid synergistically enhance the expression of nerve growth factor in human astrocytes under hypoxia/reoxygenation. Neurosci. Res. 2011, 69, 291–298.
86. Sun, Y.Y.; Li, Y.; Wali, B.; Li, Y.; Lee, J.; Heinmiller, A.; Abe, K.; Stein, D.G.; Mao, H.; Sayeed, I. et al. Prophylactic edaravone prevents transient hypoxic-ischemic brain injury: Implications for perioperative neuroprotection. Stroke J. Cereb. Circ. 2015, 46, 1947–1955.
87. Chaudhari, T.; McGuire, W. Allopurinol for preventing mortality and morbidity in newborn infants with suspected hypoxic-ischaemic encephalopathy. Cochrane Database Syst. Rev. 2008, CD006817.
88. Kaandorp, J.J.; Benders, M.J.; Rademaker, C.M.; Torrance, H.L.; Oudijk, M.A.; de Haan, T.R.; Bloemenkamp, K.W.; Rijken, M.; van Pampus, M.G.; Bos, A.F. et al. Antenatal allopurinol for reduction of birth asphyxia induced brain damage (ALLO-Trial); a randomized double blind placebo controlled multicenter study. BMC Pregnancy Childbirth 2010, 10, 8.
89. Buonocore, G.; Turrisi, G.; Kramer, B.W.; Balduini, W.; Perrone, S. New Pharmacological approaches in infants with hypoxic-ischemic encephalopathy. Curr. Pharm. Des. 2012, 18, 3086–3100.
90. Chaudhari, T.; McGuire, W. Allopurinol for preventing mortality and morbidity in newborn infants with hypoxic-ischaemic encephalopathy. Cochrane Database Syst. Rev. 2012, 7, CD006817.
91. Legido, A.; Valencia, I.; Katsetos, C.D.; Delivoria-Papadopoulos, M. Neuroprotection in perinatal hypoxic-ischemic encephalopathy. Effective treatment and future perspectives. Med. B. Aire 2007, 67, 543–555.
92. Ishijima, M.; Tsuji, K.; Rittling, S.R.; Yamashita, T.; Kurosawa, H.; Denhardt, D.T.; Nifuji, A.; Ezura, Y.; Noda, M. Osteopontin is required for mechanical stress-dependent signals to bone marrow cells. J. Endocrinol. 2007, 193, 235–243.
93. Yumoto, K.; Nifuji, A.; Rittling, S.R.; Tsuchiya, Y.; Kon, S.; Uede, T.; Denhardt, D.T.; Hemmi, H.; Notomi, T.; Hayata, T. et al. Osteopontin deficiency suppresses tumor necrosis factor-α-induced apoptosis in chondrocytes. Cartilage 2012, 3, 79–85.
94. Bonestroo, H.J.; Nijboer, C.H.; van Velthoven, C.T.; van Bel, F.; Heijnen, C.J. The neonatal brain is not protected by osteopontin peptide treatment after hypoxia-ischemia. Dev. Neurosci. 2015, 37, 142–152.
95. Gunn, A.J.; Williams, C.E.; Mallard, E.C.; Tan, W.K.; Gluckman, P.D. Flunarizine, a calcium channel antagonist, is partially prophylactically neuroprotective in hypoxic-ischemic encephalopathy in the fetal sheep. Pediatr. Res. 1994, 35, 657–663.
96. Liu, H.T.; Mu, D.Z. Inducible nitric oxide synthase and brain hypoxic-ischemic brain damage. Chin. J. Contemp. Pediatr. 2014, 16, 962–967.
97. Lu, Q.; Harris, V.A.; Rafikov, R.; Sun, X.; Kumar, S.; Black, S.M. Nitric oxide induces hypoxia ischemic injury in the neonatal brain via the disruption of neuronal iron metabolism. Redox Biol. 2015, 6, 112–121.
98. Chang, S.; Jiang, X.; Zhao, C.; Lee, C.; Ferriero, D.M. Exogenous low dose hydrogen peroxide increases hypoxia-inducible factor-1α protein expression and induces preconditioning protection against ischemia in primary cortical neurons. Neurosci. Lett. 2008, 441, 134–138.
99. Cai, J.; Kang, Z.; Liu, W.W.; Luo, X.; Qiang, S.; Zhang, J.H.; Ohta, S.; Sun, X.; Xu, W.; Tao, H. et al. Hydrogen therapy reduces apoptosis in neonatal hypoxia-ischemia rat model. Neurosci. Lett. 2008, 441, 167–172.
100. Cai, J.; Kang, Z.; Liu, K.; Liu, W.; Li, R.; Zhang, J.H.; Luo, X.; Sun, X. Neuroprotective effects of hydrogen saline in neonatal hypoxia-ischemia rat model. Brain Res. 2009, 1256, 129–137.
101. Eckermann, J.M.; Krafft, P.R.; Shoemaker, L.; Lieberson, R.E.; Chang, S.D.; Colohan, A. Potential application of hydrogen in traumatic and surgical brain injury, stroke and neonatal hypoxia-ischemia. Med. Gas Res. 2012, 2, 11.
102. Lin, S.; Rhodes, P.G.; Cai, Z. Whole body hypothermia broadens the therapeutic window of intranasally administered IGF-1 in a neonatal rat model of cerebral hypoxia-ischemia. Brain Res. 2011, 1385, 246–256.
103. Davidson, J.O.; Rout, A.L.; Wassink, G.; Yuill, C.A.; Zhang, F.G.; Green, C.R.; Bennet, L.; Gunn, A.J. Non-additive effects of delayed connexin hemichannel blockade and hypothermia after cerebral ischemia in near-term fetal sheep. J. Cereb. Blood Flow Metab. Off. J. Int. Soc. Cereb. Blood Flow Metab. 2015, 35, 2052–2061.
104. Davidson, J.O.; Green, C.R.; Bennet, L.; Nicholson, L.F.; Danesh-Meyer, H.; O’Carroll, S.J.; Gunn, A.J. A key role for connexin hemichannels in spreading ischemic brain injury. Curr. Drug Targets 2013, 14, 36–46.
105. Huang, H.M.; Yu, J.Y.; Ou, H.C.; Jeng, K.C. Effect of naloxone on the induction of immediately early genes following oxygen- and glucose-deprivation in PC12 cells. Neurosci. Lett. 2008, 438, 252–256.
106. Jiang, F.X.; Wang, S.J.; Zhong, L. Clinical observation of compound Salvia injection in treating mid-severe infantile hypoxic-ischemic encephalopathy. Chin. J. Integr. Tradit. West. Med. 2001, 21, 903–905.